文献速递颈动脉与弓上血管

症状性颈动脉疾病对CEA、TCAR与TF-CAS术后结局的差异影响

Symptomatic carotid artery disease differentially affects outcomes after carotid endarterectomy, transcarotid revascularization, and transfemoral carotid artery stenting.
PubMed 文献 · J Vasc Surg · 2026-09-08

回顾性分析2657例颈动脉血运重建患者,症状性占31.1%。无症状患者三种术式30天卒中/死亡无显著差异;症状性患者中TF-CAS的30天卒中/死亡显著高于CEA和TCAR。症状状态独立增加CEA和TF-CAS术后30天卒中/死亡风险,支持按症状分层选择术式。

要点

  • 无症状患者CEA、TCAR、TF-CAS的30天卒中/死亡无显著差异。
  • 症状性患者TF-CAS的30天卒中/死亡显著高于CEA和TCAR。
  • 症状性患者中CEA与TCAR的调整后30天卒中/死亡无显著差异。

核心结论

  • 症状性患者中TF-CAS的30天卒中/死亡高于CEA和TCAR,CEA与TCAR围术期结局相当。
  • 症状状态独立增加CEA和TF-CAS术后30天卒中/死亡风险,TCAR呈相似趋势但未达统计学显著。
  • 所有血运重建方式中症状性患者的长期无卒中生存均显著低于无症状患者。

研究设计与样本

  • 回顾性分析前瞻性维护的机构颈动脉血运重建数据库,纳入2003年3月至2025年8月接受CEA、TCAR或TF-CAS的患者。
  • 共2657例有症状状态资料,无症状1830例(68.9%),症状性827例(31.1%)。
  • 主要结局为30天卒中/死亡,采用多因素logistic回归评估术式特异性结局及症状状态与30天卒中/死亡的独立关联。

主要发现

  • 无症状患者CEA、TCAR、TF-CAS的30天卒中/死亡分别为1.8%、1.6%、2.3%(P=.843)。
  • 症状性患者CEA、TCAR、TF-CAS的30天卒中/死亡分别为4.8%、4.2%、14.5%(P=.005)。
  • 症状性患者中TF-CAS对比CEA的30天卒中/死亡OR为3.38(95%CI 1.27-9.02,P=.015),对比TCAR的OR为4.32(95%CI 1.56-11.95,P=.005)。
  • 症状性患者中TCAR对比CEA的30天卒中/死亡OR为0.78(95%CI 0.38-1.62,P=.510),卒中OR为0.69(95%CI 0.31-1.53,P=.361)。
  • 症状状态独立增加CEA术后30天卒中/死亡风险(OR 3.68,95%CI 1.77-7.64,P<.001)和TF-CAS术后风险(OR 9.12,95%CI 1.46-56.97,P=.018),TCAR未达显著(OR 2.49,95%CI 0.89-6.94,P=.082)。

关键数值与推荐

  • 症状性患者30天卒中/死亡:CEA 4.8%、TCAR 4.2%、TF-CAS 14.5%(P=.005)。
  • 无症状患者30天卒中/死亡:CEA 1.8%、TCAR 1.6%、TF-CAS 2.3%(P=.843)。
  • 症状性患者TF-CAS对比CEA的30天卒中/死亡OR 3.38(95%CI 1.27-9.02,P=.015),对比TCAR的OR 4.32(95%CI 1.56-11.95,P=.005)。

临床怎么用

  • 对症状性颈动脉疾病患者,优先选择CEA或TCAR而非TF-CAS以降低围术期卒中/死亡风险。
  • 无症状患者三种术式围术期结局相当,术式选择可综合其他因素个体化决定。
  • 症状状态应作为颈动脉血运重建术式选择的重要分层因素。

局限性

  • 回顾性单中心研究,可能存在选择偏倚和未测量混杂。
  • 症状状态资料仅2657例可用,部分患者被排除。
  • TCAR症状性亚组样本量有限,部分比较未达统计学显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Symptomatic carotid artery stenosis is associated with a greater risk of stroke than asymptomatic disease. However, the influence of symptom status on outcomes across contemporary carotid revascularization strategies remains incompletely understood. We compared perioperative and long-term outcomes following carotid endarterectomy (CEA), transcarotid artery revascularization (TCAR), and transfemoral carotid artery stenting (TF-CAS) according to symptom status. METHODS: A retrospective review of a prospectively maintained institutional carotid revascularization database was performed, including patients undergoing CEA, TCAR, or TF-CAS between March 2003 and August 2025. Patients were stratified by symptomatic vs asymptomatic presentation. The primary outcome was 30-day stroke/death. Secondary outcomes included myocardial infarction, cranial nerve injury, thrombosis, reintervention, and long-term stroke-free survival. Multivariable logistic regression was used to evaluate procedure-specific outcomes and the independent association between symptom status and 30-day stroke/death. RESULTS: A total of 2657 patients had symptom status available, including 1830 asymptomatic (68.9%) and 827 symptomatic (31.1%). Among asymptomatic patients, 30-day stroke/death did not differ significantly among CEA, TCAR, and TF-CAS (1.8%, 1.6%, and 2.3%, respectively; P = .843). In symptomatic patients, stroke/death differed significantly across procedures (4.8%, 4.2%, and 14.5%, respectively; P = .005). After adjustment, no differences in stroke/death were observed among procedures in the asymptomatic cohort. In symptomatic patients, TF-CAS was associated with higher odds of 30-day stroke/death compared with both CEA [odds ratio (OR), 3.38; 95% confidence interval (CI), 1.27-9.02; P = .015] and TCAR (OR, 4.32; 95% CI, 1.56-11.95; P = .005). Compared with CEA, TCAR demonstrated comparable adjusted odds of stroke/death (OR, 0.78; 95% CI, 0.38-1.62; P = .510) and stroke (OR, 0.69; 95% CI, 0.31-1.53; P = .361) in the symptomatic cohort. Symptomatic presentation independently increased the risk of 30-day stroke/death following CEA (OR, 3.68; 95% CI, 1.77-7.64; P < .001) and TF-CAS (OR, 9.12; 95% CI, 1.46-56.97; P = .018). A similar association was observed following TCAR, although statistical significance was not reached (OR, 2.49; 95% CI, 0.89-6.94; P = .082). The long-term stroke-free survival was significantly lower among symptomatic patients across all revascularization modalities (all log-rank P < .01). CONCLUSIONS: Among symptomatic patients, TF-CAS was associated with higher 30-day stroke/death rates compared with both CEA and TCAR. In contrast, CEA and TCAR demonstrated comparable perioperative outcomes across symptomatic and asymptomatic cohorts. These findings support symptom-stratified procedure selection and reinforce CEA and TCAR as preferred revascularization strategies for symptomatic carotid artery disease.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Baghbani A, Miles DG, Hicks T, et al. Symptomatic carotid artery disease differentially affects outcomes after carotid endarterectomy, transcarotid revascularization, and transfemoral carotid artery stenting. J Vasc Surg. 2026. PMID: 42710604. doi:10.1016/j.jvs.2026.08.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。